(Q36079907)

12 August 2017

The prognostic significance of DNA flow cytometry in breast cancer: results from 881 patients treated in a single centre (English)

1 reference

12 August 2017

1 reference

Camplejohn RS

1

1 reference

12 August 2017

Ash CM

2

1 reference

12 August 2017

Gillett CE

3

1 reference

12 August 2017

Raikundalia B

4

1 reference

12 August 2017

Barnes DM

5

1 reference

12 August 2017

Gregory WM

6

1 reference

12 August 2017

Richards MA

7

1 reference

12 August 2017

Millis RR

8

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 January 1995

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

71

1 reference

12 August 2017

1

1 reference

12 August 2017

140-145

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1995.29

12 August 2017

0 references

cites work

Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast. Report of the DNA Cytometry Consensus Conference.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033468

Histological grade, elastosis, DNA ploidy and the response to chemotherapy of breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033468

The relationship between histological grade, oestrogen receptor status, events and survival at 8 years in the NATO ('Nolvadex') trial

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033468

The prognostic significance of nuclear DNA content in invasive breast cancer--a study with long-term follow-up

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033468

Ki67 immunostaining in primary breast cancer: pathological and clinical associations

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033468

Ploidy, proliferative activity and prognosis. DNA flow cytometry of solid tumors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033468

A review of techniques and results obtained in one laboratory by an integrated system of methods designed for routine clinical flow cytometric DNA analysis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033468

DNA index, S-phase fraction, histological grade and prognosis in breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033468

Node negative breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033468

Lack of prognostic significance of DNA ploidy and S phase fraction in breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033468

Analysis of PCP-data to determine the fraction of cells in the various phases of cell cycle

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033468

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033468

Node-negative breast cancer: prognostic subgroups defined by tumor size and flow cytometry

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033468

Proliferative activity, histological grade and benefit from adjuvant chemotherapy in node positive breast cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033468

A mathematical model relating response durations to amount of subclinical resistant disease.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033468

Measurement of S-phase fractions in lymphoid tissue comparing fresh versus paraffin-embedded tissue and 4′,6′ -diamidino-2 phenylindole dihydrochloride versus propidium iodide staining

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033468

CONTROLLED TRIAL OF ADJUVANT CHEMOTHERAPY WITH MELPHALAN FOR BREAST CANCER

21 October 2018

1 reference

12 December 2020

Indicators of prognosis in node-negative breast cancer

1 reference

12 December 2020

Flow cytometric analysis of DNA content and keratins by using CK7, CK8, CK18, CK19, and KL1 monoclonal antibodies in benign and malignant human breast tumors

1 reference

12 December 2020

Markers of prognosis in breast cancer--the relationship between binding of the lectin HPA and histological grade, SPF, and ploidy

1 reference

12 December 2020

Adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with axillary node-positive breast cancer: an update of the Guy's/Manchester trial

1 reference

12 December 2020

Overexpression of the c-erbB-2 oncoprotein: why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance?

1 reference

12 December 2020

DNA flow cytometry, nuclear morphometry, mitotic indices and steroid receptors as independent prognostic factors in female breast cancer

1 reference

12 December 2020

A role for proliferative measurements in clinical oncology?

1 reference

12 December 2020

Prognostic significance of proliferative activity and ploidy in node-negative breast cancers

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1995.29

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

7819030

1 reference